Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2020-09-21
2024-12-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurobiology of Language Recovery in Aphasia: Natural History and Treatment-Induced Recovery
NCT01927302
Web-Based Treatment for Aphasia
NCT04413136
Treatment Intensity - Apraxia of Speech
NCT02332915
A Novel Treatment for Aphasia and Apraxia of Speech : Measurement of Outcomes
NCT01979159
Speech Entrainment Treatment for People With Aphasia
NCT05687994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study investigates the effects of modulating stimulus variables, specifically stimulus practice distribution and stimulus repetition. We use a baseline script treatment that has experimental support regarding its efficacy, and that allows the manipulation of these variables. To ensure independence and fidelity, treatment is provided in a controlled computer environment (desktop and tablet). To avoid clinician-related variables such as expertise and personality factors that may influence treatment, sentences are modeled during treatment by an anthropomorphic agent with high visual speech intelligibility and affective expressions.
With regard to "best outcomes", generalization is the ultimate goal of any treatment approach. Therefore, the primary outcome is a generalization measure of conversation. Secondary measures address short-term acquisition, longer-term maintenance, and stimulus and response generalization for assessing gain over baseline, differential effects, and interactions. A mobile-connected wireless wearable laryngeal sensor allows tracking of talk time at home and in the community as a measure of treatment effectiveness and transfer. For privacy, it does not record audio.
Results and computational models of learning (generalization, short-term acquisition, and longer-term maintenance) will contribute new evidence to fill critical gaps in current scientific understanding regarding the effectiveness and clinical application of aphasia treatment approaches. More generally, findings will help to inform clinical practice and treatment of neurologic communication disorders; the virtual clinician guided intervention that the proposal develops has the potential to reduce costly clinician-client time otherwise required for long-term rehabilitation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Distributed, Short Script
Participant practices for 1 hour, 2 days a week for 5 weeks using a 5 sentence-long script.
Script Training
Participant uses a computer program to practice scripts with a virtual therapist.
Distributed, Long Script
Participant practices for 1 hour, 2 days a week for 5 weeks using a 10 sentence-long script.
Script Training
Participant uses a computer program to practice scripts with a virtual therapist.
Massed, Short Script
Participant practices for 1 hour, 5 days a week for 2 weeks using a 5 sentence-long script.
Script Training
Participant uses a computer program to practice scripts with a virtual therapist.
Massed, Long Script
Participant practices for 1 hour, 5 days a week for 2 weeks using a 10 sentence-long script.
Script Training
Participant uses a computer program to practice scripts with a virtual therapist.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Script Training
Participant uses a computer program to practice scripts with a virtual therapist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Left-hemisphere stroke
* Aphasia Quotient score between 40-80 on the Western Aphasia Battery-Revised
* At least 6 months post stroke
* Completed at least eighth grade education
* Premorbidly literate in English
* Visual acuity no worse than 20/100 corrected in the better eye
* Auditory acuity no worse than 30 dB HL on pure tone testing, aided in better ear
* Not receiving speech-language therapy at the time of study
Exclusion Criteria
* Any significant psychiatric history prior to the stroke, such as severe major depression or psychotic disorder requiring hospitalization; subjects with mood disorders who are currently stable on treatment will be considered
* Active substance abuse
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Deafness and Other Communication Disorders (NIDCD)
NIH
Northwestern University
OTHER
University of Colorado, Boulder
OTHER
Shirley Ryan AbilityLab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leora Cherney
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leora Cherney, PhD, CCC-SLP
Role: PRINCIPAL_INVESTIGATOR
Shirley Ryan Abilitylab, Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shirley Ryan Abilitylab
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Center for Aphasia Research \& Treatment
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00209618
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.